Acute decompensated heart failure: formulating an evidence-based approach to diagnosis and treatment (part II).
Acute decompensated heart failure (ADHF) is a disease of enormous scope and impact. Despite significant advances in our understanding of the pathophysiology of the disease, the initial treatment of ADHF has changed little in the past 40 years. This article, the second in a two-part series, will examine the emergency department approach to ADHF, including the issues of risk stratification and goal-directed therapy. It will also review therapeutic interventions, including available medications and the role of non-invasive ventilation devices for the stabilization and treatment of ADHF.
Chest Pain Unit, Department of Emergency Medicine, Mount Sinai Medical Center, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.
Francesco
F
Buccelletti
Luke
L
Hermann
D000208:Acute Disease; D002316:Cardiotonic Agents / Q000627:therapeutic use; D018450:Disease Progression; D004232:Diuretics / Q000627:therapeutic use; D004636:Emergency Service, Hospital; D019317:Evidence-Based Medicine; D006333:Heart Failure / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D012121:Respiration, Artificial; D018570:Risk Assessment
D002316:Cardiotonic Agents; D004232:Diuretics